Cosmos Health (COSM) said Monday that it signed an exclusive agreement with Virax Biolabs to distribute mpox virus real-time PCR detection kits in India.
The deal expands the companies' strategic partnership beyond Europe and follows a recent exclusive agreement for Cosmos Health's distribution of the detection kits in the Middle East, Cosmos Health Chief Executive Officer Greg Siokas said.
No financial details were disclosed.
Price: 1.05, Change: -0.05, Percent Change: -4.55
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments